Pharmalot Ed Silverman STAT Plus: Teva and Endo reach settlements with California over pay-to-delay deals
Pharmalot Ed Silverman STAT Plus: FTC says pay-to-delay cases fell, prompting trade group to argue legislation isn’t needed
Pharmalot Ed Silverman STAT Plus: Pharmalittle: Colorado is first U.S. state to cap insulin prices; JP Morgan cuts ties with Purdue
Pharmalot Ed Silverman STAT Plus: In possible blueprint for other states, Ohio attorney general floats proposals to rein in PBMs
Pharmalot Ed Silverman STAT Plus: A growing number of states are eyeing laws to prohibit a controversial cost-sharing tool
Pharmalot Ed Silverman STAT Plus: Pharmalittle: Generic chief at Novartis unit leaves; how Ned Sharpless got to the top of the FDA
Pharmalot Ed Silverman STAT Plus: Pharmalittle: Lilly to sell version of insulin at half price; senators push drug price gouging bill
Pharmalot Ed Silverman STAT Plus: California reports show changes in drug spending as two companies sue over disclosure
First Opinion Lello Tesema and Stephen Merjavy Deported veterans should not be denied the health care they’ve earned
Pharmalot Ed Silverman STAT Plus: Mr. Quixote goes to Washington? A bill would allow Medicare to negotiate drug prices
Pharmalot Ed Silverman STAT Plus: Congress isn’t acting to curb drug prices, so states are stepping up. Here’s how
Pharmalot Ed Silverman STAT Plus: California moves closer to adopting a drug pricing transparency law
Pharmalot Ed Silverman STAT Plus: Drug pricing battle moves to Ohio as dueling ads begin over a ballot measure
Pharmalot Ed Silverman STAT Plus: Q&A: Vermont legislator says drug pricing law is the start of a ‘long battle’
Pharmalot Ed Silverman STAT Plus: Long-awaited Senate report suggests ways to blunt impact of rising drug prices
Pharmalot Ed Silverman 21st Century Cures bill would weaken requirements for disclosing industry ties